Private Equity
2 min read · 10 April 2018
Yorktown Partners appeared to have raise a $49 million venture capital fund, according to a filing with the SEC.
1 min read · 09 April 2018
Cambridge, Massachusetts-based Magenta Therapeutics, a biotechnology company focused on developing new medicines "to bring the curative power of bone marrow transplant to more patients," has closed $52 million in Series C financing. Casdin Capital led the round with participation from other investors that included EcoR1 Capital, Eventide Asset Management, Watermill Asset Management, Be the Match BioTherapies and Access Industries.
1 min read · 09 April 2018
Cambridge, Massachusetts-based Constellation Pharmaceuticals Inc, a developer of tumor-targeted and immuno-oncology therapies, has raised $100 million in financing. The investors included Cormorant Asset Management, Deerfield Management, Fidelity Management and Research Company, Hillhouse Capital, NS Investment, OrbiMed, Sirona Capital, Venrock Healthcare Partners, The Column Group, Third Rock Ventures, Venrock, SROne, University of California Investment Office, Topspin Partners and Casdin Capital.
1 min read · 09 April 2018
Cambridge, Massachusetts-based Cydan, an orphan drug accelerator, has named Dr. Imran A. Babar as chief business officer. Previously, Babar worked at OrbiMed Advisors. Cydan's backers include New Enterprise Associates, Pfizer Venture Investments, Lundbeckfonden Ventures, Longitude Capital and Alexandria Venture Investments.
3 min read · 09 April 2018
Brightspark has struck a deal with Canadian wealth manager Richardson GMP Ltd to give more domestic accredited investors an opportunity to participate in the venture capital asset class. Brightspark, a Canadian early-stage venture capital firm, operates a software platform that allows thousands of high-net-worth individuals to select technology investments online. As a result of the deal, Toronto-based Richardson GMP is the first wealth management firm to provide its clients with access to the platform. Brightspark, profiled by PE Hub Canada in February, aims to extend its strategy through similar agreements with other financial services firms.
3 min read · 09 April 2018
3 min read · 09 April 2018
2 min read · 06 April 2018
Unusual Ventures is launching a maiden fund targeting $160 million, according to a regulatory filing. The new firm is led by John Vrionis, who left his role as partner at Lightspeed Venture Partners in December 2017 to launch his own seed-stage venture fund, according to his LinkedIn profile. The new firm does not appear to have a website, and Vrionis has not yet updated his LinkedIn profile with information on the new fund.
1 min read · 06 April 2018
Saama Capital has raised a $100 million fourth venture capital fund, according to a filing with the SEC.
1 min read · 06 April 2018